- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04886752
The Effect of Liposome Vitamin C on the Absorption and Metabolism of the Human Body.
May 13, 2021 updated by: TCI Co., Ltd.
The Effect of Liposome Vitamin C on the Absorption
To evaluate the difference between vitamin C in the form of oral liposomes and general vitamin C in a fixed period of time in plasma and urine.
Study Overview
Status
Completed
Conditions
Detailed Description
we recruited 11 healthy subjects and adopted a cross-over test.
the subjects need to take 3 tests during trail.
After each test was completed, a washout period of 14 days was required before the next test start.
The subjects were informed to consume one sachet vitamin C without liposome, liposomal process A vitamin C, or liposomal process B vitamin C (Double Nutri™) every test, and vitamin C concentration was measured at baseline (0 hours), 0.5, 1, 2, 3, 4, and 8 hours after taking test sample.
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 114
- Research & Design Center, TCI CO., Ltd
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults between 20-60 years old,
- No heart, liver, kidney, endocrine and major organic diseases
Exclusion Criteria:
- Renal insufficiency and dialysis
- Cancer
- Underweight (BMI≦17) or obese (BMI≧27),
- Take chronic disease drugs,
- Blood pressure systolic blood pressure ≧130 mmHg or diastolic blood pressure ≧85 mmHg,
- Too high fasting blood glucose ≧ 100 mg/dL,
- Triglyceride ≧ 150 mg/dL,Total cholesterol ≧ 200 mg/dL,
- Have a history of vitamin C allergy,
- People with mental illness,
- Pregnant or breastfeeding women,
- Hematosis,
- Kidney stones,
- Long-term vitamin C supplements (at least 200 mg per day for more than one month)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: vitamin C without liposome
|
subjects need to take 3 tests during trail.
After each test was completed, a washout period of 14 days was required before the next test start
|
Placebo Comparator: liposomal process A vitamin C
|
subjects need to take 3 tests during trail.
After each test was completed, a washout period of 14 days was required before the next test start
|
Experimental: liposomal process B vitamin C (Double Nutri™)
|
subjects need to take 3 tests during trail.
After each test was completed, a washout period of 14 days was required before the next test start
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
vitamin c detection
Time Frame: at 8 hours after taking test sample
|
vitamin c was assessed by Ascorbic Acid Colorimetric Assay Kit II
|
at 8 hours after taking test sample
|
The change of Triglyceride
Time Frame: at 8 hours after taking test sample
|
Venous blood was sampled to measure concentrations of Triglyceride
|
at 8 hours after taking test sample
|
The change of body mass index (BMI)
Time Frame: Time 0, 0.5, 1, 2, 3, 4, and 8 hours after taking test sample
|
BMI is a measurement of a person's leanness or corpulence based on their height and weight, and is intended to quantify tissue mass.The body mass index (BMI, kg/m^2) and body mass (kg) were assessed by InBody770.
|
Time 0, 0.5, 1, 2, 3, 4, and 8 hours after taking test sample
|
The change of aspartate aminotransferase
Time Frame: at 8 hours after taking test sample
|
Venous blood was sampled to measure concentrations of aspartate aminotransferase
|
at 8 hours after taking test sample
|
The change of alanine aminotransferase
Time Frame: at 8 hours after taking test sample
|
Venous blood was sampled to measure concentrations of alanine aminotransferase
|
at 8 hours after taking test sample
|
The change of creatine
Time Frame: at 8 hours after taking test sample
|
Venous blood was sampled to measure concentrations of creatine
|
at 8 hours after taking test sample
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jaw-Shiun Tsai, Doctor, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 10, 2019
Primary Completion (Actual)
June 9, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
May 9, 2021
First Submitted That Met QC Criteria
May 13, 2021
First Posted (Actual)
May 14, 2021
Study Record Updates
Last Update Posted (Actual)
May 14, 2021
Last Update Submitted That Met QC Criteria
May 13, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Hematologic Diseases
- Nutrition Disorders
- Hemorrhagic Disorders
- Hemostatic Disorders
- Avitaminosis
- Deficiency Diseases
- Malnutrition
- Scurvy
- Ascorbic Acid Deficiency
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Protective Agents
- Micronutrients
- Antioxidants
- Vitamins
- Vitamin B Complex
- Ascorbic Acid
Other Study ID Numbers
- 201903113RSA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin C Deficiency
-
Hospices Civils de LyonRecruitingDeficiency, Vitamin CFrance
-
Jewish General HospitalCompletedVitamin D Deficiency | Vitamin C DeficiencyCanada
-
University of AberdeenUniversity of OtagoNot yet recruiting
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
SourseCitruslabsActive, not recruitingMood | Energy Supply; Deficiency | B12 Deficiency VitaminUnited States
-
University of FloridaCompleted
-
Washington University School of MedicineUniversity of California, Davis; Universidad San Francisco de Quito; Pan American...CompletedCholine Deficiency | Vitamin B-12 Deficiency | Lipids Deficiency | Amino Acids DeficiencyEcuador
-
University of FloridaNational Institutes of Health (NIH)Completed
-
Rajavithi HospitalQueen Sirikit National Institute of Child HealthCompleted
-
Universidade de Passo FundoUnknownDeficiency, Vitamin DBrazil
Clinical Trials on vitamin C without liposome
-
Johns Hopkins UniversityCompletedTobacco SmokingUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Shiraz University of Medical SciencesCompletedRestless Legs Syndrome | Kidney Failure, ChronicIran, Islamic Republic of
-
University of RochesterNot yet recruitingInflammation | FrailtyUnited States
-
Nantes University HospitalCompletedHypobetalipoproteinemiaFrance
-
PepsiCo Global R&DFood and Nutrition Research Institute, PhilippinesCompleted
-
NYU Langone HealthRecruitingTraumatic Brain InjuryUnited States
-
AronPharma Sp. z o. o.Medical University of Warsaw; Medical University of GdanskCompletedBioavailability of Vitamin CPoland
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Unresectable Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v7United States